MHRA updates guidance for semaglutide prescribers and patients
The GLP-1 receptor lowers hunger and slows down food leaving the stomach
Marx N, Burgmaier M, Heinz P, Ostertag M, Hausauer A, Bach H, et al
Anticipated retatrutide uses Obesity In the phase 2 trial of retatrutide published in the New England Journal of Medicine (NEJM), a group of 338 adults with obesity were randomly given either a placebo or one of four different doses of retatrutide: 1 mg, 4 mg, 8 mg, or 12 mg
Understanding retatrutide and why injection site matters Before discussing where to place the needle, understanding what retatrutide does in your body explains why injection site selection is not arbitrary
Room-temperature medication injected into a clean, dry thigh produces minimal discomfort for most patients